Higher levels of phosphorylated PDGFRα/β and EMT proteins were detected in spheroid cultures (enriched for cancer stem cells), while the PDGFRα/β-targeting tyrosine kinase inhibitor imatinib reduced migration and invasion up to 80% and reduced expression of EMT proteins. Here, PDGFRA is linked to cancer.